| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC32704-50mg |
|
1380723-44-3 |
Atezolizumab (MPDL3280A) - Glpbio |
0 | 需询价 | — | |
| GC32704-5mg |
|
1380723-44-3 |
Atezolizumab (MPDL3280A) - Glpbio |
0 | 需询价 | — | |
| GC32704-1mg |
|
1380723-44-3 |
Atezolizumab (MPDL3280A) - Glpbio |
0 | 需询价 | — | |
| GC32703-100mg |
|
1492952-76-7 |
Asciminib (ABL001) - Glpbio |
0 | 需询价 | C20H18ClF2N5O3 | |
| GC32703-50mg |
|
1492952-76-7 |
Asciminib (ABL001) - Glpbio |
0 | 需询价 | C20H18ClF2N5O3 | |
| GC32703-25mg |
|
1492952-76-7 |
Asciminib (ABL001) - Glpbio |
0 | 需询价 | C20H18ClF2N5O3 | |
| GC32703-10mg |
|
1492952-76-7 |
Asciminib (ABL001) - Glpbio |
0 | 需询价 | C20H18ClF2N5O3 | |
| GC32703-5mg |
|
1492952-76-7 |
Asciminib (ABL001) - Glpbio |
0 | 需询价 | C20H18ClF2N5O3 | |
| GC32703-1mg |
|
1492952-76-7 |
Asciminib (ABL001) - Glpbio |
0 | 需询价 | C20H18ClF2N5O3 | |
| GC32703-10mM(1mLinDMSO) |
|
1492952-76-7 |
Asciminib (ABL001) - Glpbio |
0 | 需询价 | C20H18ClF2N5O3 | |
| GC32702-50mg |
|
1562338-42-4 |
Branaplam (LMI070) - Glpbio |
0 | 需询价 | C22H27N5O2 | |
| GC32702-10mg |
|
1562338-42-4 |
Branaplam (LMI070) - Glpbio |
0 | 需询价 | C22H27N5O2 | |
| GC32702-5mg |
|
1562338-42-4 |
Branaplam (LMI070) - Glpbio |
0 | 需询价 | C22H27N5O2 | |
| GC32702-2mg |
|
1562338-42-4 |
Branaplam (LMI070) - Glpbio |
0 | 需询价 | C22H27N5O2 | |
| GC32702-10mM(1mLinDMSO) |
|
1562338-42-4 |
Branaplam (LMI070) - Glpbio |
0 | 需询价 | C22H27N5O2 | |
| GC32701-100mg |
|
1305115-80-3 |
PF-04957325 - Glpbio |
0 | 需询价 | C14H15F3N8OS | |
| GC32701-50mg |
|
1305115-80-3 |
PF-04957325 - Glpbio |
0 | 需询价 | C14H15F3N8OS | |
| GC32701-10mg |
|
1305115-80-3 |
PF-04957325 - Glpbio |
0 | 需询价 | C14H15F3N8OS | |
| GC32701-5mg |
|
1305115-80-3 |
PF-04957325 - Glpbio |
0 | 需询价 | C14H15F3N8OS | |
| GC32701-1mg |
|
1305115-80-3 |
PF-04957325 - Glpbio |
0 | 需询价 | C14H15F3N8OS | |
小泰
|
010-60710855
|